PSA is still the main tool for early detection, risk stratification, and monitoring of PCa.
However, PSA values are affected by many technical and biological factors. Instead of using …

OBJECTIVE To determine, within the UK, the stage and grade of prostate cancers that would
be found through population‐based prostate specific antigen (PSA) testing and biopsy …

Background: The use of prostate-specific antigen (PSA) for early detection of prostate cancer
is a widely debated issue. The average Indian urologist is faced with the dilemma of whether …

PURPOSE: To test the discrimination and calibration properties of the newly developed
2007 Partin Tables in two European cohorts with localized prostate cancer. METHODS: Data …

Background: The aim of this study was to document the epidemiological features of prostate
cancer in Iranand to define its public health priorities for an early detection program …

Objective. To investigate whether survival rates published in the EUROCARE studies for
Tyrol are distorted, we evaluated data quality in the Cancer Registry of Tyrol. Material and …

OBJECTIVES: The Sexual Health Inventory for Men (SHIM) is a widely used scale for the
screening and diagnosis of erectile dysfunction (ED). Our objective was to incorporate the …

Introduction Erectile dysfunction (ED) is one of the complications after radical retropubic
prostatectomy (RRP), and recovery of erectile function is quantitatively related to the …

Radical prostatectomy in the treatment of prostate cancer. The experience of the Urology Clinic
of „Prof. Dr. Th. Burghele” Clinical Hospital - PMC Back to Top Skip to main content NIH NLM …

Background The high prevalence and incidence of prostate cancer is a global phenomenon
[1, 2]. In the pre-Prostate Specific Antigen (PSA) era, the clinical hallmarks of prostate cancer …